Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma.
Laganà M, Habra MA, Remde H, Almeida MQ, Cosentini D, Pusceddu S, Grana CM, Corssmit EPM, Bongiovanni A, De Filpo G, Lim ES, Zamparini M, Grisanti S, Deutschbein T, Fassnacht M, Fagundes GFC, Pereira MAA, Oldani S, Rota S, Prinzi N, Jimenez C, Berruti A. Laganà M, et al. Among authors: cosentini d. Eur J Cancer. 2024 Sep;208:114122. doi: 10.1016/j.ejca.2024.114122. Epub 2024 Jul 3. Eur J Cancer. 2024. PMID: 39047533 Free article.
In vitro antitumor activity of progesterone in human adrenocortical carcinoma.
Fragni M, Fiorentini C, Rossini E, Fisogni S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM, Claps M, Cosentini D, Salvi V, Bosisio D, Terzolo M, Missale C, Facchetti F, Memo M, Berruti A, Sigala S. Fragni M, et al. Among authors: cosentini d. Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26. Endocrine. 2019. PMID: 30367443 Free article.
Immunotherapy failure in adrenocortical cancer: where next?
Cosentini D, Grisanti S, Dalla Volta A, Laganà M, Fiorentini C, Perotti P, Sigala S, Berruti A. Cosentini D, et al. Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398. Endocr Connect. 2018. PMID: 30400026 Free PMC article.
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review.
Fornaro C, Piubeni M, Tovazzi V, Cosentini D, Gelmi M, Rota G, Berta B, Barucco W, Lombardi E, Moles L, Faustini T, Fettolini T, Motta P, Ferrari VD, Berruti A, Conti E. Fornaro C, et al. Among authors: cosentini d. Eur J Cancer Care (Engl). 2019 Mar;28(2):e12978. doi: 10.1111/ecc.12978. Epub 2018 Dec 10. Eur J Cancer Care (Engl). 2019. PMID: 30536872
Antineoplastic activity of artemisinin in adrenocortical carcinoma.
Lorini L, Grisanti S, Ambrosini R, Cosentini D, Laganà M, Grazioli L, Tiberio GAM, Sigala S, Berruti A. Lorini L, et al. Among authors: cosentini d. Endocrine. 2019 Nov;66(2):425-427. doi: 10.1007/s12020-019-02077-7. Epub 2019 Sep 6. Endocrine. 2019. PMID: 31493273 No abstract available.
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆.
Fragni M, Palma Lopez LP, Rossini E, Abate A, Cosentini D, Salvi V, Vezzoli S, Poliani PL, Bosisio D, Hantel C, Tiberio GAM, Grisanti S, Memo M, Terzolo M, Berruti A, Sigala S. Fragni M, et al. Among authors: cosentini d. Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16. Mol Cell Endocrinol. 2019. PMID: 31536779
76 results